Progress and Market Development of Biotechnology in Saudi Arabia: A Survey

Abstract

Background: Biotechnology is a transformative field with applications in healthcare, agriculture, and industry. Saudi Arabia has prioritized biotechnology under Vision 2030, aiming to diversify its economy and establish itself as a regional biotech hub. Initiatives like the Saudi Genome Program and regulatory reforms by the SFDA highlight progress, yet challenges such as workforce shortages, import dependency, and ethical concerns persist. This study examines the perceptions of biotechnology professionals in Saudi Arabia regarding sectoral progress, regulatory efficiency, and market opportunities, focusing on genetic research, precision medicine, and industrial biotechnology under Vision 2030. Materials and Methods: A descriptive-analytical design was employed, targeting 150 biotechnology researchers, industry professionals, and policymakers via purposive sampling. Data were collected through a validated Likert-scale questionnaire assessing regulatory adequacy, collaboration, local manufacturing, and import challenges. Quantitative analysis was performed using SPSS v20.0. Results: While 40% agreed that SFDA regulations support genetic testing growth, 35.3% reported insufficient academia-industry-government collaboration. Optimism was high for local manufacturing (76.7%) and Saudi Arabia’s potential as a regional biotech hub (83.4%). However, 67.3% faced import barriers, and 87.3% noted delays hindering research. Genetic data privacy concerned 55.3%, while 90.7% endorsed global partnerships for innovation. Conclusion: Saudi Arabia’s biotechnology sector shows promise under Vision 2030, with strong potential in local manufacturing and regional leadership. However, regulatory harmonization, enhanced collaboration, and infrastructure investment are critical to overcoming import dependencies and workforce gaps. Strategic policy interventions are recommended to sustain growth and innovation.